UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Comparative changes in renal gene expressions in chronic kidney disease and vitamin D deficient mouse models

Drug metabolism and pharmacokinetics, 2019-01, Vol.34 (1), p.S18-S18

2019

Volltextzugriff (PDF)

To the Editor

Anesthesia and analgesia, 2019-06, Vol.128 (6), p.e125-e126

2019

Volltextzugriff (PDF)

Tranexamic Acid Dosing for Cardiac Surgical Patients With Chronic Renal Dysfunction: A New Dosing Regimen

Anesthesia and analgesia, 2018-12, Vol.127 (6), p.1323-1332

2018

Volltextzugriff (PDF)

Noteworthy Idiosyncrasies of 1α,25‐Dihydroxyvitamin D 3 Kinetics for Extrapolation from Mouse to Man

The FASEB journal, 2020-04, Vol.34 (S1), p.1-1

2020

Volltextzugriff (PDF)

Current Evidence and Future Directions of Tranexamic Acid Use, Efficacy, and Dosing for Major Surgical Procedures

Journal of cardiothoracic and vascular anesthesia, 2020-03, Vol.34 (3), p.782-790

2020

Volltextzugriff (PDF)

Highlighting Vitamin D Receptor–Targeted Activities of 1α,25-Dihydroxyvitamin D^sub 3^ in Mice via Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling

Drug metabolism and disposition, 2018-01, Vol.46 (1), p.75

2018

Volltextzugriff (PDF)

Response to letter to the editor on "fractional clearance for verapamil N-demethylation in the isolated rat liver preparation"

Drug metabolism and disposition, 2015-07, Vol.43 (7), p.1058-1059

2015

Volltextzugriff (PDF)

Highlighting Vitamin D Receptor-Targeted Activities of 1 α ,25-Dihydroxyvitamin D 3 in Mice via Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling

Drug metabolism and disposition, 2018-01, Vol.46 (1), p.75-87

2018

Volltextzugriff (PDF)

Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors

Investigational new drugs, 2021-12, Vol.39 (6), p.1587-1597

2021

Volltextzugriff (PDF)

123: PHARMACOKINETICS OF TRANEXAMIC ACID IN CARDIAC SURGICAL PATIENTS SUFFERING FROM KIDNEY DYSFUNCTION

Critical care medicine, 2016-12, Vol.44 (12 Suppl 1), p.108-108

2016

Volltextzugriff (PDF)

Highlighting Vitamin D Receptor-Targeted Activities of 1α,25-Dihydroxyvitamin D3 in Mice via Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling

Drug metabolism and disposition, 2018-01, Vol.46 (1), p.75-87

2018

Volltextzugriff (PDF)

To the Editor

Anesthesia and analgesia, 2019-06, Vol.128 (6), p.e125-e126

2019

Volltextzugriff (PDF)

To the Editor

Anesthesia and analgesia, 2019-06, Vol.128 (6), p.e125

2019

Volltextzugriff (PDF)

To the Editor

Anesthesia and analgesia, 2019-04

2019

Volltextzugriff (PDF)

Unequivocal evidence supporting the segregated flow intestinal model that discriminates intestine versus liver first‐pass removal with PBPK modeling

Biopharmaceutics & drug disposition, 2017-04, Vol.38 (3), p.231-250

2017

Volltextzugriff (PDF)

Metabolite Kinetics: The Segregated Flow Model for Intestinal and Whole Body Physiologically Based Pharmacokinetic Modeling to Describe Intestinal and Hepatic Glucuronidation of Morphine in Rats In Vivo

Drug metabolism and disposition, 2016-07, Vol.44 (7), p.1123-1138

2016

Volltextzugriff (PDF)

Pharmacokinetic modeling of tranexamic acid for patients undergoing cardiac surgery with normal renal function and model simulations for patients with renal impairment

Biopharmaceutics & drug disposition, 2015-07, Vol.36 (5), p.294-307

2015

Volltextzugriff (PDF)

Noteworthy idiosyncrasies of 1α,25-dihydroxyvitamin D 3 kinetics for extrapolation from mouse to man: Commentary

Biopharmaceutics & drug disposition, 2020-03, Vol.41 (3), p.126-148

2020

Volltextzugriff (PDF)

Physiologically-Based Pharmacokinetic-Pharmacodynamic Modeling of 1α,25-Dihydroxyvitamin D3 in Mice

Drug metabolism and disposition, 2016-02, Vol.44 (2), p.189-208

2016

Volltextzugriff (PDF)

Noteworthy idiosyncrasies of 1α,25‐dihydroxyvitamin D3 kinetics for extrapolation from mouse to man: Commentary

Biopharmaceutics & drug disposition, 2020-03, Vol.41 (3), p.126-148

2020

Volltextzugriff (PDF)

Model-Guided Transdermal Formulation of 1α,25-Dihydroxyvitamin D3 for Improved Safety and Efficacy

Yang, Qi (Joy)

2019

Volltextzugriff (PDF)

Comparing early liver graft function from heart beating and living‐donors: A pilot study aiming to identify new biomarkers of liver injury

Biopharmaceutics & drug disposition, 2017-07, Vol.38 (5), p.326-339

2017

Volltextzugriff (PDF)

To the Editor

Anesthesia and analgesia, 2019-06, Vol.128 (6), p.e125-e126

2019

Volltextzugriff (PDF)

To the Editor

Anesthesia and analgesia, 2019-04

2019

Volltextzugriff (PDF)

4.05 - PBPK Modeling to Estimate Metabolite Formation From First-Pass Organs: Intestine and Liver

Comprehensive Medicinal Chemistry III, 2017, p.83-101

Third Edition, 2017

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Englisch
(36)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparative changes in renal gene expressions in chronic kidney disease and vitamin D deficient mouse models

To the Editor

Tranexamic Acid Dosing for Cardiac Surgical Patients With Chronic Renal Dysfunction: A New Dosing Regimen

Noteworthy Idiosyncrasies of 1α,25‐Dihydroxyvitamin D 3 Kinetics for Extrapolation from Mouse to Man

Current Evidence and Future Directions of Tranexamic Acid Use, Efficacy, and Dosing for Major Surgical Procedures

Highlighting Vitamin D Receptor–Targeted Activities of 1α,25-Dihydroxyvitamin D^sub 3^ in Mice via Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling

Response to letter to the editor on "fractional clearance for verapamil N-demethylation in the isolated rat liver preparation"

Highlighting Vitamin D Receptor-Targeted Activities of 1 α ,25-Dihydroxyvitamin D 3 in Mice via Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling

Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors

123: PHARMACOKINETICS OF TRANEXAMIC ACID IN CARDIAC SURGICAL PATIENTS SUFFERING FROM KIDNEY DYSFUNCTION

Highlighting Vitamin D Receptor-Targeted Activities of 1α,25-Dihydroxyvitamin D3 in Mice via Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling

To the Editor

To the Editor

To the Editor

Unequivocal evidence supporting the segregated flow intestinal model that discriminates intestine versus liver first‐pass removal with PBPK modeling

Metabolite Kinetics: The Segregated Flow Model for Intestinal and Whole Body Physiologically Based Pharmacokinetic Modeling to Describe Intestinal and Hepatic Glucuronidation of Morphine in Rats In Vivo

Pharmacokinetic modeling of tranexamic acid for patients undergoing cardiac surgery with normal renal function and model simulations for patients with renal impairment

Noteworthy idiosyncrasies of 1α,25-dihydroxyvitamin D 3 kinetics for extrapolation from mouse to man: Commentary

Physiologically-Based Pharmacokinetic-Pharmacodynamic Modeling of 1α,25-Dihydroxyvitamin D3 in Mice

Noteworthy idiosyncrasies of 1α,25‐dihydroxyvitamin D3 kinetics for extrapolation from mouse to man: Commentary

Model-Guided Transdermal Formulation of 1α,25-Dihydroxyvitamin D3 for Improved Safety and Efficacy

Comparing early liver graft function from heart beating and living‐donors: A pilot study aiming to identify new biomarkers of liver injury

To the Editor

To the Editor

4.05 - PBPK Modeling to Estimate Metabolite Formation From First-Pass Organs: Intestine and Liver

Suchergebnisse filtern